- Brett Icahn and Richard Mulligan join IFF's board, effective Oct. 20.
- Icahn replaces Vincent Intrieri, and Mulligan replaces Margarita Paláu-Hernández.
- Icahn joins the Audit and Transaction Committees; Mulligan joins the Innovation Committee.
Board Appointments
IFF has appointed Brett Icahn and Richard Mulligan to its board of directors, effective October 20. These appointments are part of a cooperation agreement with Icahn Capital LP and its affiliates.
Committee Assignments
Brett Icahn will serve on the Board’s Audit and Transaction Committees, while Richard Mulligan will join the Innovation Committee. Icahn replaces Vincent Intrieri, and Mulligan replaces Margarita Paláu-Hernández, both of whom stepped down on October 20.
Background of Appointees
Brett Icahn is an investor and portfolio manager at Icahn Capital LP, involved in sectors like investment, automotive, and energy. He has served on various boards, including SandRidge Energy Inc. and CVR Energy.
Richard Mulligan, Ph.D., is the Mallinckrodt Professor of Genetics emeritus at Harvard Medical School. He has held roles at MIT and Sarissa Capital Management LP, and serves on the board of Sana Biotechnology Inc.
